1Rivera E,Valero V,Arun B,et al.PhaseⅡ study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer[J].J Clin Oncol,2003,21(17):324.
2Gabriela V,Kornek,Karin Haider,et al.Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factorl[J].Clinical Cancer Research,2002,8(5):1051-1056.
5Nagourney RA,Link JS,Blitzer JB,et al.Gemcitabine plus cisplatin repeating doublet therapy in previously treated,relapsed Replased breast cancer patients[J].J Clin Oncol,2000,18(11):2245.
6Stemmler J,Bischoff J,Untch M,et al.Gemcitabine and cisplatin in heavily pretreated metastatic breast cancer[J].Onkologie,2000,23(suppl 7):60.
7Silvestris N,D'Aprile M,Andreola G,et al.Rationale for the use of gemcitabine in breast cancer(Review)[J].Int J Oncol,2004,24(2):389-98.
8Heinemann V.Role of gemcitabine in the treatment of advanced and metastatic breast cancer[J].Oncology,2003,64(3):191-206.
二级参考文献19
1[1]Heinemann V. Gemcitabine plus cisplatin for the treatment of metastatic breast cancer[ J]. Clin Breast Cancer,2002,3 (Suppl 1 ): S24-S29.
2[2]Seidman AD. Gemcitabine as single-agent therapy in the management of advanced breast cancer [ J ]. Oncology, 2001,15(2) (Suppl 3): 11-14.
3[3]Jurga L,Misurova E, Kovac V, et al. The role of cisplatin in chemotherapy of advanced breast cancer[J]. Neoplasma, 1994,41 ( 6 ) :347-352.
4[4]Carmichael J, Walling J. Advanced breast cancer:investigational role of gemcitabine[ J]. Eur J Cancer, 1997,33( Suppl 1 ): S27-S31.
5[5]Pegram MD, Lipton A, Hayes DF, et al. Phase Ⅱ study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment [ J ]. J Clin Oncol, 1998, 16(8) :2659-2671.
6[6]Ray-Coquard Ⅰ, Biron P, Bachelot T, et al. Vinorelbine and cisplatin ( CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline-and/or paclitaxelcontaining regimens[ J]. Cancer, 1998 ,82 ( 1 ): 134-140.
7[7]Vassilomanolakis M, Koumakis G, Barbounis V, et al.Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines [ J ]. Ann Oncol, 2000,11(5) :1155-1160.
8[8]Moorsel CJ, Veerman G, Bergman AM, et al. Combination chemotherapy studies with gemcitabine[ J]. Semin Oncol, 1997,2,4(2): S7-S23.
9[9]Nagourney RA, Evans SS, Makalinao AJ, et al. Gemcitabine activity in primary cultures of human caner ( Abstract 2161 )[J]. Proc Am Assoc Cancer Res, 1996,37: 318.
10[1]Blackstein M, Vogel CL, Ambinder R, et al. Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase Ⅱ trial[J]. Oncology, 2002,62(1): 2～8
